Hermed Capital has agreed to to acquire 20 million shares in DiaMedica Inc for $4 million. Based in Minneapolis and Canada, DiaMedica is a biopharmaceutical company focused on treating neurological and kidney diseases.
GrowthCurve Capital takes majority stake in medication access platform TailorMed
4 hours ago · 1 min read
OpenGate Capital completes carve-out of Maersk Training from Maersk
6 hours ago · 1 min read
Stonepeak completes acquisition of 65% Castrol stake from BP
7 hours ago · 1 min read
Livingbridge backs launch of accounting group Apteus after seven acquisitions
9 hours ago · 2 mins read
DPE-backed CirQono acquires Saxony demolition firm ORA in add-on deal
12 hours ago · 2 mins read
Charterhouse agrees to sell Vermeg stake to Advent, with ADIA co-investing
13 hours ago · 2 mins read
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
30 October 2026 · 2 mins read
